Rapid Dose Therapeutics Corp. (RDTCF)

Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 28, 2026	Feb 28, 2025	Feb 29, 2024	Feb 28, 2023	Feb 28, 2022	Feb 28, 2021
Market Capitalization	13	15	15	7	21	13
Market Cap Growth	-38.67%	0.45%	121.72%	-67.18%	56.53%	-32.70%
Enterprise Value	18	17	17	8	22	15
Last Close Price	0.10	0.18	0.02	0.00	0.20	0.19
PS Ratio	6.72	10.56	20.20	12.98	15.10	22.43
PB Ratio	-2.81	-4.23	-6.53	-3.49	105.16	-15.54
P/TBV Ratio	-	-	-	-	105.16	-
EV/Sales Ratio	8.60	11.79	23.00	15.75	15.81	24.39
Debt / Equity Ratio	-0.87	-0.50	-0.78	-0.79	5.70	-2.01
Asset Turnover	1.02	1.19	0.49	0.27	0.51	0.19
Inventory Turnover	5.88	4.25	2.79	1.67	1.26	0.43
Quick Ratio	0.05	0.05	0.13	0.04	0.09	0.08
Current Ratio	0.08	0.10	0.23	0.09	0.25	0.19
Return on Assets (ROA)	-70.49%	-148.14%	-93.37%	-83.34%	-77.93%	-25.16%
Return on Capital Employed (ROCE)	69.20%	80.10%	298.70%	134.20%	-698.60%	392.80%
Earnings Yield	-23.37%	-24.54%	-20.89%	-40.87%	-32.08%	-10.66%
FCF Yield	-4.66%	-5.23%	-11.13%	-9.27%	-11.49%	-9.64%
Buyback Yield / Dilution	-7.98%	-18.68%	-1.50%	-3.19%	-28.83%	-2.23%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.